NexgenRx
Financial Software · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
191 The West Mall Ste 905, Toronto, Onta...Phone Number
(416) 695-3393Website
www.nexgenrx.comRevenue
$10.7 MillionStock Symbol
NXGIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
1
1
1
About NexgenRx
NexgenRx develops innovative technology platforms that empower clients to manage group benefit plans, group pension plans, and patient support programs efficiently. With almost two decades of experience, their software-as-a-service solutions cater to plan sponsors, providers, and drug manufacturers, enhancing claims management and plan administration. Key offerings include NexSys for claims processing, NexAdmin for plan management, and NexPension for pension administration, all aimed at reducing costs and improving health outcomes. The company serves a broad clientele, covering over one million lives and processing one billion claim payments annually.Explore more
NexgenRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NexgenRx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once NexgenRx has new funding data
Earning: See what the market has to say on NexgenRx recently announced quarterly report
NexgenRx, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if NexgenRx had a recent Job posting/layoffs
Product Launch: Get notified when NexgenRx launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at NexgenRx
Check if NexgenRx has recently received funding, and reach out quickly before it becomes old news!
Check out if NexgenRx is spiking on competitors!
Recommended Actions
Find VP level buyers at NexgenRx
Find 3 more new buyers
Compare Similar Companies to NexgenRx
Compare insights from companies similar to NexgenRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NexgenRx is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
NexgenRx is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about NexgenRx.
NexgenRx Tech Stack
A closer look at the technologies used by NexgenRx
See more technologies
NexgenRx News & Media
NexgenRx Announces 2022 Year End Results With Continued Revenue Growth And Positive EBITDA
NEXGENRX INC.("NexgenRx" or the "Company") is pleased to announce its annual financial results for the financial year ended December 31, 2022, once again highlighted by continued revenue growth and positive EBIDTA. The Company showed revenue growth of $939,942 in 2022 or 7.94% over the prior year, with a positive EBITDA of $1,626,524.Is NexgenRx Inc.'s (CVE:NXG) Recent Stock Performance Tethered To Its Strong Fundamentals?
NexgenRx's (CVE:NXG) stock is up by a considerable 30% over the past three months. Since the market usually pay for a...NexgenRx Announces Q3 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Free Cash Flow
NEXGENRX INC.("NexgenRx" or the "Company") is pleased to announce its interim financial results for the third quarter ended September 30, 2022, highlighted by continued revenue growth, positive EBIDTA and increased free cash flow. During Q3 2022, the Company showed revenue growth of 15.81% over the same period last year. Revenue for the third quarter was $3,317,358 and $9,401,460 year-to-date.Nexgenrx Announces Declaration Of Dividend
NEXGENRX INC.("NexgenRx" or the "Company") is pleased to announce that a dividend in the amount of one-half of one cent per share ($0.005) has been declared in respect of all of its outstanding common shares and series 1 preferred shares. This dividend will be payable on or before October 10, 2022 to all shareholders of record as at the close of business on October 3, 2022.
Read more news
Top Financial Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding NexgenRx
Sign Up For FreeTo access detailed company insights
NexgenRx develops innovative technology platforms that empower clients to manage group benefit plans, group pension plans, and patient support programs efficiently. With almost two decades of experience, their software-as-a-service solutions cater to plan sponsors, providers, and drug manufacturers, enhancing claims management and plan administrati... Read More
